TENAX THERAPEUTICS, INC. (TENX) Insider Trading -- Recent Executive & Director Transactions

5 insiders reported 18 Form 4 transactions for TENAX THERAPEUTICS, INC. (TENX) over the past 18 months (most recent 2026-07-14). Recent activity: Giordano Christopher Thomas (CEO) Buy 8,500 shares, Giordano Christopher Thomas (CEO) Buy 219 shares, STAAB THOMAS R II (Chief Financial Officer) Buy 10,000 shares, Rich Stuart (Chief Medical Officer) Buy 2,500 shares, Rich Stuart (Chief Medical Officer) Buy 2,500 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-14Giordano Christopher ThomasCEOBuy8,500$50,490
2026-07-14Giordano Christopher ThomasCEOBuy219$777
2026-05-13STAAB THOMAS R IIChief Financial OfficerBuy10,000$0
2025-12-10Rich StuartChief Medical OfficerBuy2,500$25,250
2025-12-10Rich StuartChief Medical OfficerBuy2,500$25,550
2025-12-05Rich StuartChief Medical OfficerBuy1,000$9,010
2025-12-05Rich StuartChief Medical OfficerBuy1,500$13,620
2025-12-05Rich StuartChief Medical OfficerBuy2,500$23,000
2025-11-20Giordano Christopher ThomasCEOBuy455$3,417
2025-11-20Giordano Christopher ThomasCEOBuy1,612$12,493
2025-11-20Giordano Christopher ThomasCEOBuy538$4,083
2025-11-20Almenoff June SherieDirectorBuy93$665
2025-11-20Almenoff June SherieDirectorBuy1,900$14,288
2025-11-19MCGAULEY THOMASInterim CFOBuy2,000$14,680
2025-11-19MCGAULEY THOMASInterim CFOBuy1,000$7,350
2025-11-19MCGAULEY THOMASInterim CFOBuy5,000$36,150
2025-11-19Almenoff June SherieDirectorBuy93$665
2025-11-19Almenoff June SherieDirectorBuy1,900$14,288

Source: SEC Form 4 filings · as of 2026-07-14